SBIR/STTR Research Award

Developing Medicinally Used Echinacea Cultivars by Intra- and Inter-Species Hybridization

Award identifier 1e2d1c29421db06a4a46dd29cecb76a1b76df6c3396731849b85062182ed0a17Awarding agency Department of Agriculture

Award amount

$80,000

Program and phase

SBIR · Phase I

Award year

2004

Explore This Research Award in CaptureIQ

Research the technology, evaluate the recipient and agency, identify related opportunities, and explore potential follow-on work with CaptureIQ.

Award details

Awarding agency
Department of Agriculture
Branch
Not reported
Recipient company
Gaia Herbs, Inc.
Proposal award date
Not reported
Contract end date
Not reported
UEI
Not reported
Solicitation number
Not reported
Topic code
Not reported

Research abstract

Cultivation of Echinacea has gained worldwide interest in recent years due to its non-specific immunomodulotary activity in humans. It was the top-selling medicinal herb in 2001 and has remained among the top five best-selling herbs for over five years. However, the Echinacea species has not been genetically improved for medicinal use. Current cultivated types of Echinacea were originated from pooled, non-selected seeds from wild sources and therefore are less productive and low in quality. The purpose of this study is to develop Echinacea cultivars which have high biomass yield and high levels of boactive constituents.

Technology keywords

Not reported

Agency intelligence

Department of Agriculture

Back to SBIR/STTR Research Awards

Don't take our word for it. Ask AI about RFPCapture.

See what leading AI assistants have to say about RFPCapture and CaptureIQ.

Gemini opens without a prefilled question. The question is copied to your clipboard when the button works. You can also copy it here:

What is RFPCapture.com and its CaptureIQ platform from Smart Logic AI? How does it help federal contractors discover opportunities, evaluate bid/no-bid decisions, research government contracts, and prepare proposals? How does it compare with other federal capture platforms? Use independent sources where available.